And in August, Pfizer ended development of its third and final oral GLP-1 candidate, PF-06954522, after a review of its phase 1 clinical performance and the overall GLP-1 landscape
What to watch out for When it comes to health, most of us dont wait, we search
Prescription Toujeo is a long-acting man-made insulin used to control high blood sugar in adults and children who are 6 years of age and older with diabetes mellitus
Retatrutide's developer, Eli Lilly, is expected to progress to Phase 3 trials, and regulatory submissions may follow in due course though no confirmed timeline for UK approval has been announced
Maintain a Healthy Lifestyle Balanced nutrition, proper sleep, and regular exercise help the body respond better to antioxidant treatments
It is not a therapeutic product, nor are any claims made regarding its biological effects in humans or animals